Phil Gallagher

2.3k citations
30 papers · 1.2k · 1 hit paper · h-index 16

Impact in

  • Rheumatology top 0.5%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 5%
    • Psoriasis: Treatment and Pathogenesis
    • T-cell and B-cell Immunology

Papers in

  • Rheumatology 19
    • Spondyloarthritis Studies and Treatments 14
    • Rheumatoid Arthritis Research and Therapies 5
    • Systemic Lupus Erythematosus Research 3
  • Immunology 5
    • T-cell and B-cell Immunology 1
Co-authors
Oliver FitzGerald (10 shared papers)Muhammad Haroon (6 shared papers)Eric Heffernan (3 shared papers)Douglas J. Veale (9 shared papers)Ursula Fearon (9 shared papers)Philip Helliwell (2 shared papers)Brian Kirby (2 shared papers)Laura C. Coates (2 shared papers)
Journals
The Journal of Rheumatology (3 papers)Arthritis Research & Therapy (3 papers)Lara D. Veeken (3 papers)Annals of the Rheumatic Diseases (3 papers)Seminars in Arthritis and Rheumatism (2 papers)
Partner nations
IrelandUnited StatesUnited Kingdom

In The Last Decade

Phil Gallagher

28 papers receiving 1.2k citations

Phil Gallagher's Hit Papers

Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis 2014 · 426 citations
4260+4+8Years since publication100200300400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2014 Annals of the Rheumatic Diseases

Peers

Phil Gallagher
Comparison fields: 5 of 70
  • Rheumatology 889
  • Immunology 468
  • Hematology 211
  • Dermatology 38
  • Complementary and Manual Therapy 6
Replace Naonobu Sugiyama with:
Naonobu Sugiyama Japan
Carmen Castro Spain
G. Schett Germany
E Taccari Italy
Daiki Nakagomi Japan
I. Koetter Germany
EK Li Hong Kong
Yukiko Komano Japan
A Studnicka-Benke Austria
Guro Løvik Goll Norway
Phil Gallagher relative to Naonobu Sugiyama Japan Naonobu Sugiyama's profile →
Citations per field
00.5×2×4×6×
Naonobu Sugiyama · 1×
Citations per year

Countries citing papers authored by Phil Gallagher

Since Specialization
Citations

This map shows the geographic impact of Phil Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Gallagher more than expected).

Fields of papers citing papers by Phil Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Gallagher. The network helps show where Phil Gallagher may publish in the future.

Co-authors

The 25 scholars most cited alongside Phil Gallagher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phil Gallagher Line = papers co-authored together Phil Gallagher links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
Annals of the Rheumatic Diseases ·Muhammad Haroon, Phil Gallagher, Oliver FitzGerald
Hit paper breakdown →		2014426
2
Development of a preliminary composite disease activity index in psoriatic arthritis
Annals of the Rheumatic Diseases ·Aizad Mumtaz, Phil Gallagher, Brian Kirby, Robin Waxman, Laura C. Coates, Michael J. Dale, Philip Helliwell, Oliver FitzGerald
2010155
3
High Prevalence of Metabolic Syndrome and of Insulin Resistance in Psoriatic Arthritis is Associated with the Severity of Underlying Disease
The Journal of Rheumatology ·Muhammad Haroon, Phil Gallagher, Eric Heffernan, Oliver FitzGerald
2014134
4
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial
Seminars in Arthritis and Rheumatism ·Richard Conway, Lorraine O’Neill, Phil Gallagher, Géraldine McCarthy, Conor C. Murphy, Douglas J. Veale, Ursula Fearon, Eamonn Molloy
201871
5
MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE
Journal of Autoimmunity ·Siobhán Smith, Thilini R. Fernando, Pei Wu, Jane J. Seo, Joan Ní Gabhann, Olga Piskareva, Eoghan McCarthy, Donough Howard, Paul G. O’Connell, Richard Conway, Phil Gallagher, Eamonn Molloy, Raymond L. Stallings, Grainne Kearns, Lindsy Forbess, Mariko Ishimori, Swamy Venuturupalli, Daniel J. Wallace, Michael H. Weisman, Caroline A. Jefferies
201755
6
Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease
Clinical & Translational Immunology ·Trudy McGarry, Megan M. Hanlon, Viviana Marzaioli, Clare C. Cunningham, Vinod Krishna, Kieran Murray, Conor Hurson, Phil Gallagher, Sunil Nagpal, Douglas J. Veale, Ursula Fearon
202154
7
The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status?
Arthritis Care & Research ·Laura C. Coates, Xenofon Baraliakos, Francisco J. Blanco, E. Alonso Blanco-Morales, Jürgen Braun, Vinod Chandran, J.L. Fernández-Sueiro, Oliver FitzGerald, Phil Gallagher, Dafna D. Gladman, Е. Е. Gubar, Т. В. Коротаева, Е. Yu. Loginova, Ennio Lubrano, Juan Mulero, J. Pinto-Tasende, Rubén Queiró, Jesús Sanz, Ágnes Szentpétery, Philip Helliwell
202053
8
Higher Coronary Plaque Burden in Psoriatic Arthritis Is Independent of Metabolic Syndrome and Associated With Underlying Disease Severity
Arthritis & Rheumatology ·Ágnes Szentpétery, Gerard M. Healy, Darragh Brady, Muhammad Haroon, Phil Gallagher, Ciaran E. Redmond, Hannah Fleming, John Duignan, Jonathan D. Dodd, Oliver FitzGerald
201743
9
Long-term remission and biologic persistence rates: 12-year real-world data
Arthritis Research & Therapy ·Kieran Murray, Matthew Turk, Yousef Alammari, Francis Young, Phil Gallagher, T. Saber, Ursula Fearon, Douglas J. Veale
202133
10
Loss of balance between protective and pro-inflammatory synovial tissue T-cell polyfunctionality predates clinical onset of rheumatoid arthritis
Annals of the Rheumatic Diseases ·Achilleas Floudas, Nuno Neto, Carl Orr, Mary Canavan, Phil Gallagher, Conor Hurson, Michael G. Monaghan, Sunil Nagpar, Ronan Mullan, Douglas J. Veale, Ursula Fearon
202131
11
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Arthritis Research & Therapy ·Ágnes Szentpétery, Eric Heffernan, Martina Gogarty, Lisa Mellerick, Janet McCormack, Muhammad Haroon, Musaab Elmamoun, Phil Gallagher, Genevieve Kelly, Aurélie Fabre, Brian Kirby, Oliver FitzGerald
201729
12
Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder
Arthritis Research & Therapy ·Emese Balogh, João Marcos Domingues Dias, Carl Orr, Ronan Mullan, Len Harty, Oliver FitzGerald, Phil Gallagher, Miriam Molloy, Eileen O’Flynn, Alexia Kelly, Patricia Minnock, Madeline O’Neill, Louise Moore, Mairead Murray, Ursula Fearon, Douglas J. Veale
201327
13
Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset
Science Advances ·Megan M. Hanlon, Conor M. Smith, Mary Canavan, Nuno Neto, Qingxuan Song, Myles Lewis, Aoife M. O’Rourke, Orla Tynan, Brianne E. Barker, Phil Gallagher, Ronan Mullan, Conor Hurson, Barry Moran, Michael G. Monaghan, Costantino Pitzalis, Jean M. Fletcher, Sunil Nagpal, Douglas J. Veale, Ursula Fearon
202426
14
Multimorbidity in Axial Spondyloarthropathy and Its Association with Disease Outcomes: Results from the Ankylosing Spondylitis Registry of Ireland Cohort
The Journal of Rheumatology ·Gillian Fitzgerald, Phil Gallagher, Finbar O’Shea
201922
15
Functionally Mature CD1c+ Dendritic Cells Preferentially Accumulate in the Inflammatory Arthritis Synovium
Frontiers in Immunology ·Mary Canavan, Viviana Marzaioli, Vipul Bhargava, Sunil Nagpal, Phil Gallagher, Conor Hurson, Ronan Mullan, Douglas J. Veale, Ursula Fearon
202122
16
Striking difference of periarticular bone density change in early psoriatic arthritis and rheumatoid arthritis following anti-rheumatic treatment as measured by digital X-ray radiogrammetry
Lara D. Veeken ·Ágnes Szentpétery, Eric Heffernan, Muhammad Haroon, Mark Kilbane, Phil Gallagher, Malachi J. McKenna, Oliver FitzGerald
201615
17
Central Obesity in Axial Spondyloarthritis: The Missing Link to Understanding Worse Outcomes in Women?
The Journal of Rheumatology ·Sinead Maguire, Fiona Wilson, Phil Gallagher, Finbar O’Shea
20228
18
What to expect when women with axial spondyloarthritis are expecting: Prevalence of complications of pregnancies in women with axial spondyloarthritis
Seminars in Arthritis and Rheumatism ·Sinead Maguire, Fiona Wilson, Phil Gallagher, Muhanad MS Mohamed, Senan Maher, Finbar O’Shea
20227
19
112. DELAYED DIAGNOSIS OF AXIAL SPONDYLOARTHROPATHY IS ASSOCIATED WITH A HIGHER PREVALENCE OF DEPRESSION
Lara D. Veeken ·Gillian Fitzgerald, Phil Gallagher, Catherine O’Sullivan, Killian O’Rourke, C. Sheehy, Francis Stafford, Carmel Silke, Ronan Mullan, Mohammed Haroon, Oliver FitzGerald, B. O’Shea
20176
20
Distinct clinical outcomes linked to peripheral arthritis and dactylitis in axial spondyloarthritis: findings from a retrospective Irish cohort
Rheumatology International ·Marcus Kenyon, Phil Gallagher, Brona Dinneen, Finbar O’Shea, Ross McManus
20245

About Phil Gallagher

Phil Gallagher is a scholar working on Rheumatology, Immunology, Pulmonary and Respiratory Medicine, Physiology and Political Science and International Relations, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (14 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Systemic Lupus Erythematosus Research (3 papers), Simulation-Based Education in Healthcare (1 paper), Vasculitis and related conditions (1 paper), Gender, Labor, and Family Dynamics (1 paper), T-cell and B-cell Immunology (1 paper) and Fiscal Policy and Economic Growth (1 paper). The work is most often cited by research in Rheumatology (889 citations), Immunology (468 citations), Hematology (211 citations), Dermatology (38 citations) and Complementary and Manual Therapy (6 citations). Phil Gallagher has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Oliver FitzGerald, Muhammad Haroon, Eric Heffernan, Douglas J. Veale, Ursula Fearon, Philip Helliwell, Brian Kirby, Laura C. Coates, Michael J. Dale and Robin Waxman. Their work appears in journals such as The Journal of Rheumatology, Arthritis Research & Therapy, Lara D. Veeken, Annals of the Rheumatic Diseases and Seminars in Arthritis and Rheumatism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naonobu SugiyamaBreakdown of academic impact, for papers by Carmen CastroBreakdown of academic impact, for papers by G. SchettBreakdown of academic impact, for papers by E TaccariBreakdown of academic impact, for papers by Daiki NakagomiBreakdown of academic impact, for papers by I. KoetterBreakdown of academic impact, for papers by EK LiBreakdown of academic impact, for papers by Yukiko KomanoBreakdown of academic impact, for papers by A Studnicka-BenkeBreakdown of academic impact, for papers by Guro Løvik Goll